Template:SUIT-006 O2 ce-pce D029: Difference between revisions
From Bioblast
No edit summary |
No edit summary |
||
Line 11: | Line 11: | ||
|- | |- | ||
| 1PM | | 1PM | ||
| [[PM]]<sub>''L''</sub> | | [[PM]]<sub>''[[L]]''</sub> | ||
| [[N]] | | [[N]] | ||
| CI | | CI | ||
| | | 1PM | ||
{{Template:SUIT N}} {{Template:SUIT L(n)}} | *{{Template:SUIT N}} | ||
*{{Template:SUIT L(n)}} | |||
|- | |- | ||
| 2D | | 2D | ||
| [[PM]]<sub>''P''</sub> | | [[PM]]<sub>''[[OXPHOS|P]]''</sub> | ||
| [[N]] | | [[N]] | ||
| CI | | CI | ||
| 1PM;2D | | 1PM;2D | ||
{{Template:SUIT N}} {{Template:SUIT OXPHOS}} | *{{Template:SUIT N}} | ||
*{{Template:SUIT OXPHOS}} | |||
|- | |- | ||
| 2c | | 2c | ||
| [[PM]]c<sub>''P''</sub> | | [[PM]]c<sub>''[[OXPHOS|P]]''</sub> | ||
| [[N]] | | [[N]] | ||
| CI | | CI | ||
| 1PM;2D;2c | | 1PM;2D;2c | ||
{{Template:SUIT N}} {{Template:SUIT OXPHOS}} {{Template:SUIT c}} | *{{Template:SUIT N}} | ||
*{{Template:SUIT OXPHOS}} | |||
*{{Template:SUIT c}} | |||
|- | |- | ||
| | | 3(Omy) | ||
| [[PM]]<sub>'' | | [[PM]]<sub>''[[L]]''</sub> | ||
| [[N]] | | [[N]] | ||
| CI | | CI | ||
| 1PM;2D; | | 1PM;2D;2c;3Omy | ||
{{Template:SUIT | *{{Template:SUIT L(Omy)}} ย | ||
*The addition of [[oligomycin]] is optional depending on the experimental question to resolve. If it is known that ''L''<sub>n</sub> has the same values for ''L''<sub>Omy</sub> for a kind of sample and substrates, this step may be skipped. If the carrier of oligomycin (EtOH) is used instead, it is possible to evaluate whether it affects OXPHOS. In these cases, LEAK state is not reached again. | |||
|- | |- | ||
| | | 4U | ||
| [[PM]]<sub>''[[E]]''</sub> | |||
| [[N]] | |||
| CI | |||
| 1PM;2D;2c;3Omy;4U | |||
ย | |||
*{{Template:SUIT N}} | |||
*{{Template:SUIT U*}} | |||
ย | |||
|- | |||
| 5Ama | |||
| [[ROX]] | | [[ROX]] | ||
| ย | | ย | ||
|ย ย | |ย ย | ||
| {{Template:SUIT Ama}} | | 1PM;2D;2c;3Omy;4U;5Ama | ||
ย | |||
*{{Template:SUIT Ama}} | |||
|} | |} | ||
{{Template:Keywords in SUIT protocols}} | {{Template:Keywords in SUIT protocols}} |
Revision as of 09:47, 28 January 2019
Steps and respiratory states
Step | State | Pathway | Q-junction | Comment - Events (E) and Marks (M) |
---|---|---|---|---|
ce1 | ROUTINE | ce1
| ||
1Dig | REN | ce1;1Dig
|
Step | State | Pathway | Q-junction | Comment - Events (E) and Marks (M)
|
---|---|---|---|---|
1PM | PML | N | CI | 1PM
|
2D | PMP | N | CI | 1PM;2D
|
2c | PMcP | N | CI | 1PM;2D;2c
|
3(Omy) | PML | N | CI | 1PM;2D;2c;3Omy
|
4U | PME | N | CI | 1PM;2D;2c;3Omy;4U
|
5Ama | ROX | 1PM;2D;2c;3Omy;4U;5Ama
|
- Bioblast links: SUIT protocols - >>>>>>> - Click on [Expand] or [Collapse] - >>>>>>>
- Coupling control
- Pathway control
- ยป Electron transfer pathway
- ยป Fatty acid oxidation pathway control state, F
- ยป NADH electron transfer-pathway state, N
- ยป Succinate pathway control state, S
- ยป NS-pathway control state, NS
- ยป Glycerophosphate pathway control state, Gp
- ยป Complex IV single step, CIV
- ยป Anaplerotic pathway control state
- Pathway control
- Main fuel substrates
- ยป Glutamate, G
- ยป Glycerophosphate, Gp
- ยป Malate, M
- ยป Octanoylcarnitine, Oct
- ยป Pyruvate, P
- ยป Succinate, S
- Main fuel substrates
- Glossary